Xenon increases inducement equity plan share reserve from 900k to 1.175M shares

Xenon Pharmaceuticals Inc.

Amended 2025 Inducement Plan to raise maximum shares reserved from 900,000 to 1,175,000, a 30.6% increase.
Shares are reserved exclusively for inducement grants (nonstatutory options, RSUs, etc.) to new employees.
Amendment approved by independent directors; shareholder approval not obtained per Nasdaq Rule 5635(c)(4).
Plan amended effective April 7, 2026; full text filed as Exhibit 10.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.